Henan Lingrui Pharmaceutical's low P/E ratio is due to its p...

Henan Lingrui Pharmaceutical's low P/E ratio is due to its projected growth being less than the broader market. Investors anticipate limited future growth and are only prepared to pay a lower price for the stock, making a significant share price increase unlikely soon.